VICTORY CAPITAL MANAGEMENT INC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$249,231
-26.2%
12,081
+5.5%
0.00%
Q2 2023$337,919
+25.2%
11,451
-2.3%
0.00%
Q1 2023$269,983
-26.8%
11,718
-11.6%
0.00%
Q4 2022$368,649
+3.3%
13,256
+14.0%
0.00%
Q3 2022$357,000
+11.6%
11,625
+6.8%
0.00%
Q2 2022$320,000
+23.6%
10,8830.0%0.00%
Q1 2022$259,000
-51.9%
10,883
-9.9%
0.00%
Q4 2021$539,000
-50.8%
12,081
-44.3%
0.00%
-100.0%
Q3 2021$1,095,000
-66.9%
21,708
-48.5%
0.00%
-66.7%
Q2 2021$3,304,000
+50.9%
42,121
+9.8%
0.00%
+50.0%
Q1 2021$2,190,000
+40.8%
38,355
+106.6%
0.00%0.0%
Q4 2020$1,555,000
+247.9%
18,567
+48.9%
0.00%
+100.0%
Q3 2020$447,000
+40.6%
12,468
-5.1%
0.00%
Q2 2020$318,000
-33.5%
13,139
-51.8%
0.00%
Q1 2020$478,000
+101.7%
27,246
+100.5%
0.00%
Q4 2019$237,000
+0.4%
13,587
-12.0%
0.00%
Q3 2019$236,00015,4350.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders